NEW YORK, June 25, 2024 /PRNewswire/ -- The global cell culture consumables market  size is estimated to grow by USD 48.26 billion from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of almost 31.31%  during the forecast period. 

The cell culture consumables market is thriving, fueled by the rise of biopharmaceutical production and the growing adoption of single-use technologies. These disposable tools are revolutionizing cell culture by streamlining production and reducing costs. However, the market faces a significant challenge: contamination.

Research report provides comprehensive data on impact of trend. For more details- Download a Sample Report

Here's a breakdown of the key trends:

Growth Drivers:

• Biopharma Boom: The increasing demand for vaccines and protein therapeutics is driving the need for cell culture consumables, especially media, sera, and reagents.
• Single-Use Advantage: Single-use technologies offer a cost-effective and efficient way to manufacture biopharmaceuticals. They eliminate the need for cleaning and sterilization, saving time and money.
• Research Advancements: Growing research in areas like stem cell therapy and gene editing is creating a demand for specialized cell culture consumables.

Challenges to Address:

• Contamination Risk: Impurities in media, water, and equipment can contaminate cell cultures, leading to financial losses and hampering productivity.

Market Segments:

• Biopharma Production: This dominates the market due to the high demand for consumables in vaccine and protein manufacturing.
• Cancer Research: A substantial segment due to the use of cell culture in developing cancer treatments.
• Other Applications: This includes drug discovery, toxicology testing, and cell-based therapies.

Geographic Landscape:

• North America: Currently leads the market, but Asia is expected to see significant growth due to rising investment in biotechnology.

Future Outlook:

The cell culture consumables market is projected for continued growth due to advancements in biopharmaceuticals and research. Innovation in areas like contamination control and cost-effective solutions will be crucial for sustained market expansion.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

• Application
• • Biopharmaceutical Production
  • Cancer Research
  • Others
• Geography
• • North America
  • Europe
  • Asia
  • Rest Of World (ROW)

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/cell-culture-consumables-market-size-is-set-to-grow-by-usd-48-26-billion-from-2024-2028--rise-in-production-of-cell-culture-based-viral-vaccines-to-boost-the-market-growth-technavio-302181398.html

SOURCE Technavio